Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02636725
Title Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Breelyn Wilky
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.